Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $9.7800 (0.93%) ($9.5600 - $9.8500) on Wed. Feb. 13, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.75% (three month average) | RSI | 65 | Latest Price | $9.7800(0.93%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -0.1% a day on average for past five trading days. | Weekly Trend | IOVA advances 5.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(49%) XBI(48%) ARKG(47%) IWO(43%) ARKK(41%) | Factors Impacting IOVA price | IOVA will decline at least -2.375% in a week (0% probabilities). VXX(-13%) VIXM(-8%) UUP(-7%) IFRA(-4%) TLT(-3%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.375% (StdDev 4.75%) | Hourly BBV | 0 () | Intraday Trend | 0.7% | | | |
|
5 Day Moving Average | $9.69(0.93%) | 10 Day Moving Average | $9.63(1.56%) | 20 Day Moving Average | $9.25(5.73%) | To recent high | -6.3% | To recent low | 30.2% | Market Cap | $1.432b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |